The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia

Abstract

Except for inconsequential differences in albumin and ZAP70 expression, there was no difference in the baseline characteristics between patients with CLL who had monoallelic or biallelic deletion of 13q. In addition, there was no significant difference in endpoints, including time to treatment.